Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	145.32	62.41	33.79	43.05	65.47	112.35
Short-Term Investments	76.25	128.61	35.71	24.69	17.38	-
Cash & Short-Term Investments	221.57	191.01	69.5	67.74	82.85	112.35
Cash Growth	9.36%	174.85%	2.60%	-18.24%	-26.26%	2566.65%
Accounts Receivable	10.33	11.66	4.8	16.12	7.19	1.42
Other Receivables	12.16	11.6	5.71	1.26	1.11	0.11
Receivables	22.49	23.26	10.51	17.38	8.3	1.53
Inventory	2.45	1.74	1.97	-	-	-
Prepaid Expenses	4.79	7	4.05	1.82	1.69	0.89
Other Current Assets	-	-	-	-	-	0.29
Total Current Assets	251.3	223.01	86.03	86.94	92.83	115.06
Property, Plant & Equipment	2.31	1.7	1.01	1.53	1.78	2.03
Long-Term Investments	38.61	47.88	6.01	-	20	15.42
Goodwill	4.7	4.7	4.7	4.7	-	-
Other Intangible Assets	5.79	6.42	68.99	69.23	-	-
Other Long-Term Assets	0	1.02	11.38	9.94	0.72	0.44
Total Assets	302.71	284.73	178.13	172.33	115.34	132.94

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	13.96	2.48	13.08	13.99	3.61	0.52
Accrued Expenses	11.78	21.31	18.31	18.97	7.21	2.52
Short-Term Debt	-	-	-	37.7	-	-
Current Portion of Leases	0.63	0.42	0.42	0.54	0.49	0.37
Current Income Taxes Payable	20.84	13.71	-	-	-	-
Other Current Liabilities	1.42	1.36	2.26	2.52	0.71	0.82
Total Current Liabilities	48.63	39.28	34.07	73.72	12.02	4.23
Long-Term Debt	-	61.93	59.5	5.07	12.8	-
Long-Term Leases	0.87	0.86	0.37	0.46	0.84	1.24
Other Long-Term Liabilities	35.56	28.01	44.52	31.22	14.55	0.36
Total Liabilities	85.06	130.07	138.46	110.46	40.22	5.82

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	606.26	588.46	555.3	472.66	436.27	396.96
Retained Earnings	-375.42	-422.06	-505.29	-399.78	-353.73	-267.03
Treasury Stock	-10.98	-10.98	-10.98	-10.98	-7.54	-2.81
Comprehensive Income & Other	-2.22	-0.76	0.63	-0.04	0.11	-
Shareholders' Equity	217.65	154.66	39.67	61.86	75.12	127.12
Total Liabilities & Equity	302.71	284.73	178.13	172.33	115.34	132.94

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.5	63.21	60.3	43.77	14.13	1.61
Net Cash (Debt)	220.07	127.81	9.2	23.97	68.72	110.74
Net Cash Growth	56.82%	1289.18%	-61.62%	-65.11%	-37.95%	-
Net Cash Per Share	3.69	2.23	0.20	0.68	1.99	3.72
Filing Date Shares Outstanding	59.38	58.71	54.12	41.85	34.54	34.42
Total Common Shares Outstanding	59.34	56.85	53.67	41.53	34.54	35.01
Working Capital	202.67	183.73	51.96	13.22	80.81	110.83
Book Value Per Share	3.67	2.72	0.74	1.49	2.17	3.63
Tangible Book Value	207.16	143.54	-34.03	-12.06	75.12	127.12
Tangible Book Value Per Share	3.49	2.52	-0.63	-0.29	2.17	3.63
Machinery	-	0.66	1.36	1.51	1.28	1.05
Leasehold Improvements	-	0.14	0.71	0.71	0.71	0.72

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error